These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7342200)

  • 1. [Sensitivity of Bacteroides of the fragilis group to various antibiotics].
    de la Torre Misiego F; Betriú Cabecerán C; López Bartolomé O; Rodriguez Avial C; López Doriga
    Rev Clin Esp; 1981 Dec; 163(6):387-90. PubMed ID: 7342200
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1993 Sep; 101(9):727-31. PubMed ID: 8240792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics of choice against Bacteroides fragilis.
    Bittner J; Voinescu V; Munteanu V; Antohi M; Ardeleanu J
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):213-8. PubMed ID: 7159211
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the disc-plate method in Bacteroides fragilis].
    García Rodríguez JA; García Sánchez JE; Gómez Garciá AC; Prieto Prieto J
    Rev Clin Esp; 1977 Aug 15-31; 146(3-4):161-6. PubMed ID: 918321
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains.
    Betriu C; Sánchez A; Palau ML; Gómez M; Picazo JJ
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2372-4. PubMed ID: 11451700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sensitivity of Bacteroides fragilis to antibiotics].
    Gaspar MC; Ponte MC; Soriano F
    Rev Clin Esp; 1981 Oct; 163(2):111-2. PubMed ID: 7330342
    [No Abstract]   [Full Text] [Related]  

  • 7. Carbapenem resistance in Bacteroides fragilis.
    Ang L; Brenwald NP; Walker RM; Andrews J; Fraise A
    J Antimicrob Chemother; 2007 May; 59(5):1042-4. PubMed ID: 17363423
    [No Abstract]   [Full Text] [Related]  

  • 8. National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000.
    Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Rihs J; Gorbach SL
    Clin Infect Dis; 2002 Sep; 35(Suppl 1):S126-34. PubMed ID: 12173121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro effects of cefotetan on anaerobic bacteria of the genus Bacteroides fragilis group, in comparison with 8 antibiotics].
    Trevisan R; Proietti A; Pitzus E
    G Ital Chemioter; 1985; 32(2):367-70. PubMed ID: 3869115
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibility testing of anaerobic bacteria.
    Citron D
    Am J Med Technol; 1983 Nov; 49(11):769-72. PubMed ID: 6316785
    [No Abstract]   [Full Text] [Related]  

  • 11. Determinants of resistance in Bacteroides fragilis strains according to recent Brazilian profiles of antimicrobial susceptibility.
    Paula GR; Falcão LS; Antunes EN; Avelar KE; Reis FN; Maluhy MA; Ferreira MC; Domingues RM
    Int J Antimicrob Agents; 2004 Jul; 24(1):53-8. PubMed ID: 15225862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activity of 9 antimicrobials against Bacteroides fragilis].
    Betriu Cabecerán C; Cogollos Agruña R; García Alonso G; Agra Valero M
    Rev Clin Esp; 1988 Feb; 182(3):134-6. PubMed ID: 3285381
    [No Abstract]   [Full Text] [Related]  

  • 13. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.
    Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Golan Y; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Yu V; Rihs J; Gorbach SL
    Antimicrob Agents Chemother; 2007 May; 51(5):1649-55. PubMed ID: 17283189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
    Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
    Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of antimicrobial activity of amoxycillin/clavulanic acid against Bacteroides fragilis group.
    García-Rodriguez JA; Garcia Sanchez JE; Munoz Bellido JL; Trujillano I
    J Chemother; 1989 Jul; 1(4 Suppl):76-7. PubMed ID: 16312311
    [No Abstract]   [Full Text] [Related]  

  • 16. A simple tube test for assessing antibiotic sensitivity of certain anaerobic bacteria.
    Shivers WF; Graber CD
    J Egypt Med Assoc; 1976; 59(1-2):150-4. PubMed ID: 1032368
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of the inoculum effect on minimal inhibitory concentrations of 3 derivatives of 5-nitro-imidazole and 11 other antibiotics on Bacteroides fragilis].
    Dusart G; Simeon de Buochberg M; Maillols H; Zuccarelli M; Attisso MA
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):685-9. PubMed ID: 3054748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
    Snydman DR; Jacobus NV; McDermott LA
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4492-6. PubMed ID: 18838581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early susceptibility test results with the Bacteroides fragilis group.
    Aldridge KE
    J Antimicrob Chemother; 1993 Dec; 32(6):910-2. PubMed ID: 8144437
    [No Abstract]   [Full Text] [Related]  

  • 20. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
    Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
    Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.